Compare Stille AB with Similar Stocks
Dashboard
1
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 9.03
2
Healthy long term growth as Net Sales has grown by an annual rate of 31.82%
3
Positive results in Dec 25
4
With ROE of 7.93%, it has a fair valuation with a 2.40 Price to Book Value
5
Market Beating performance in long term as well as near term
Stock DNA
Pharmaceuticals & Biotechnology
SEK 2,116 Million (Small Cap)
30.00
NA
0.00%
-0.19
8.41%
2.85
Revenue and Profits:
Net Sales:
179 Million
(Quarterly Results - Mar 2026)
Net Profit:
21 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-0.84%
0%
-0.84%
6 Months
12.38%
0%
12.38%
1 Year
18.0%
0%
18.0%
2 Years
112.61%
0%
112.61%
3 Years
94.24%
0%
94.24%
4 Years
100.0%
0%
100.0%
5 Years
139.84%
0%
139.84%
Stille AB for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
31.82%
EBIT Growth (5y)
45.07%
EBIT to Interest (avg)
9.03
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.22
Sales to Capital Employed (avg)
0.71
Tax Ratio
18.46%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
17.21%
ROE (avg)
9.60%
Valuation key factors
Factor
Value
P/E Ratio
30
Industry P/E
Price to Book Value
2.40
EV to EBIT
19.85
EV to EBITDA
15.28
EV to Capital Employed
2.68
EV to Sales
2.79
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
13.52%
ROE (Latest)
7.93%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
179.10
174.90
2.40%
Operating Profit (PBDIT) excl Other Income
37.50
28.80
30.21%
Interest
4.90
1.00
390.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
20.90
30.20
-30.79%
Operating Profit Margin (Excl OI)
161.90%
164.50%
-0.26%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 2.40% vs 26.01% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is -30.79% vs 3,255.56% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
567.60
570.00
-0.42%
Operating Profit (PBDIT) excl Other Income
109.00
136.50
-20.15%
Interest
4.20
5.00
-16.00%
Exceptional Items
0.00
-24.10
100.00%
Consolidate Net Profit
55.70
58.20
-4.30%
Operating Profit Margin (Excl OI)
128.10%
161.00%
-3.29%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -0.42% vs 93.29% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -4.30% vs 118.80% in Dec 2024
About Stille AB 
Stille AB
Pharmaceuticals & Biotechnology
Stille AB is a Sweden-based company engaged in the development, manufacture, and marketing of technical medical equipment. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.
Company Coordinates 
Company Details
Ekbacken 11 , TORSHAELLA None : 644 30
Registrar Details






